Inventor · disambiguated record
Eunkyung An
Also filed as: AN EUNKYUNG
7 granted patents·4 pending applications·15 citations·filing 2015–2018
77Inventor score
Top patents by PatentIndex Score
11 records- 0185US9746477B2Quantifying FR-α and GART proteins for optimal cancer therapyEXPRESSION PATHOLOGY INC·Filed 2016·Granted Aug 29, 2017·11 cites·17 claims
- 0281US10060927B2SRM/MRM assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Aug 28, 2018·2 cites·14 claims
- 0376US10073075B2SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Sep 11, 2018·1 cites·14 claims
- 0472US10126307B2SRM/MRM assay for the androgen receptor (AR) proteinEXPRESSION PATHOLOGY INC·Filed 2015·Granted Nov 13, 2018·1 cites·12 claims
- 0567US10620184B2SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) proteinNANTOMICS LLC·Filed 2018·Granted Apr 14, 2020·0 cites·17 claims
- 0661US2019056406A1SRM/MRM Assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) proteinNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 0752US10078084B2SRM/MRM assay for the mesothelin (MSLN) proteinEXPRESSION PATHOLOGY INC·Filed 2016·Granted Sep 18, 2018·0 cites·14 claims
- 0842US10208130B2Quantifying Her2 protein for optimal cancer therapyEXPRESSION PATHOLOGY INC·Filed 2016·Granted Feb 19, 2019·0 cites·16 claims
- 0940US2016313343A1SRM Assay for PD-L1EXPRESSION PATHOLOGY INC·Filed 2016·Application pending·0 cites
- 1039US2017168055A1SRM/MRM AssaysEXPRESSION PATHOLOGY INC·Filed 2016·Application pending·0 cites
- 1134US2017168057A1Srm assays to chemotherapy targetsEXPRESSION PATHOLOGY INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eunkyung An files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →